Ep210: Cameron Turtle on Long-Lasting Antibodies for Immune Disorders
Sep 23, 2026 - 01:03:57
Radio and PodcastLive Radio & PodcastsThe Long Run with Luke Timmerman by The Long Run with Luke Timmerman
Ep194: Ansu Satpathy on Cancer and Autoimmune Drug Discovery by Timmerman Report
Continue listening to more episodes from The Long Run with Luke Timmerman.
Sep 23, 2026 - 01:03:57
Cameron Turtle, CEO of Waltham, Mass.-based Spyre Therapeutics, on developing long-lasting antibodies for...
Sep 9, 2026 - 01:36:12
Mathai Mammen, CEO of Cambridge, Mass.-based Parabilis Medicine, on developing alpha helical peptide mole...
Aug 25, 2026 - 01:07:17
Gary Nabel, CEO of Weston, Mass.-based ModeX Therapeutics, on developing a vaccine for Epstein-Barr Virus...
Aug 11, 2026 - 01:17:31
Jason Coloma, CEO of South San Francisco-based Maze Therapeutics, on developing small molecule drugs base...
Jul 28, 2026 - 01:07:17
Lyn Baranowski, CEO of Boston-based Avalyn Pharma, on developing inhalable medicines for severe lung dise...
Jul 14, 2026 - 01:08:18
Heather Turner, CEO of New York-based LB Pharma, on developing a new schizophrenia drug designed to bette...
Jun 30, 2026 - 01:07:27
Troy Wilson, CEO of San Diego-based Kura Oncology, on his career in biotech and developing targeted cance...
Jun 16, 2026 - 01:11:43
Sri Kosuri, co-founder and CEO of Emeryville, Calif.-based Octant Bio, on small molecules designed to cor...